This meta-analysis showed that the GS was a common disease and affected the health of one in twenty people worldwide. Accurate estimates of the global and population-based prevalence of GS are helpful for healthcare improvements.
No takes yet. Share an insight, caveat, or question.
Ning et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: